Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Selecta Biosciences (SELB)

Selecta Biosciences (SELB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 136,766
  • Shares Outstanding, K 155,204
  • Annual Sales, $ 110,780 K
  • Annual Income, $ 35,380 K
  • EBIT $ -47 M
  • EBITDA $ -46 M
  • 60-Month Beta 0.84
  • Price/Sales 1.34
  • Price/Cash Flow 9.91
  • Price/Book 2.07
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.22
  • Most Recent Earnings $-0.07 on 08/17/23
  • Next Earnings Date 11/16/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.03
  • Low Estimate -0.10
  • Prior Year -0.01
  • Growth Rate Est. (year over year) -500.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8100 +8.79%
on 11/13/23
1.3000 -32.22%
on 10/31/23
-0.1988 (-18.41%)
since 10/13/23
3-Month
0.8100 +8.79%
on 11/13/23
1.3000 -32.22%
on 10/31/23
-0.2188 (-19.89%)
since 08/11/23
52-Week
0.8100 +8.79%
on 11/13/23
1.9900 -55.72%
on 02/14/23
-0.6588 (-42.78%)
since 11/11/22

Most Recent Stories

More News
Cellarity Strengthens Executive Leadership Team

Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are discovered, announced today the appointments of John Leaman, M.D., M.B.A., as Chief Financial Officer...

IMPL : 0.0400 (-27.27%)
SELB : 0.8812 (-8.00%)
MDGN : 5.57 (+3.15%)
DNLI : 24.22 (-0.82%)
EVLO : 0.0005 (-66.67%)
FHTX : 7.72 (-1.78%)
MRNA : 38.25 (+3.55%)
OMGA : 0.7760 (-1.80%)
SANA : 2.35 (-7.11%)
MCRB : 0.7318 (-10.09%)
Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout Meets Primary Endpoint: Swedish Orphan Biovitrum AB

/PRNewswire/ -- Selecta Biosciences, Inc. (NASDAQ: SELB) and Sobi®, today announced positive topline results from the Phase 3 DISSOLVE I & II placebo...

SELB : 0.8812 (-8.00%)
Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease

/PRNewswire/ -- Selecta Biosciences, Inc. (NASDAQ: SELB, President and CEO: Carsten Brunn, Ph.D., "Selecta"), and Astellas Pharma Inc. (TSE: 4503, President...

SELB : 0.8812 (-8.00%)
Selecta Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update

– Completed enrollment of DISSOLVE II, triggering a $10 million milestone payment obligation from Swedish Orphan Biovitrum AB (publ.) (Sobi); DISSOLVE I...

SELB : 0.8812 (-8.00%)
Selecta Biosciences to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...

SELB : 0.8812 (-8.00%)
Selecta Biosciences to Host Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Business Update

WATERTOWN, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...

SELB : 0.8812 (-8.00%)
Selecta Biosciences Announces Partnership Advancements and Clinical Trial Updates

-Sarepta extends Research License and Option Agreement for ImmTOR® in Duchenne Muscular Dystrophy and certain Limb-Girdle Muscular Dystrophies- -Selecta...

SELB : 0.8812 (-8.00%)
Selecta Biosciences to Participate at the H.C. Wainwright Global Investment Conference

WATERTOWN, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...

SELB : 0.8812 (-8.00%)
Selecta Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update

– Phase 1 trial of SEL-302 remains on track to initiate in the second half of 2022 – – DISSOLVE I & II studies on track for completion in Q4 2022 with...

SELB : 0.8812 (-8.00%)
Selecta Biosciences Announces Six Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Data to be featured in two oral presentations and four poster presentations...

SELB : 0.8812 (-8.00%)

Business Summary

Selecta Biosciences, Inc. is a biopharmaceutical company which develops targeted immunotherapies and vaccines. Its product pipelineincludes gene therapy, food allergy, malaria; SEL-212, which is a therapeutic enzyme indicated for refractory gout; SEL-070, which is indicated for smoking cessation and...

See More

Key Turning Points

3rd Resistance Point 1.0740
2nd Resistance Point 1.0069
1st Resistance Point 0.9441
Last Price 0.8812
1st Support Level 0.8142
2nd Support Level 0.7471
3rd Support Level 0.6843

See More

52-Week High 1.9900
Fibonacci 61.8% 1.5392
Fibonacci 50% 1.4000
Fibonacci 38.2% 1.2608
Last Price 0.8812
52-Week Low 0.8100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar